Steve Innaimo is the head of the Covance Program Management Office and possesses more than 25 years of drug development experience in the pharma, biotech and CRO settings. Steve began his career as molecular biologist developing novel targeted gene therapies. During his 22 years with BMS, he held positions of increasing responsibility within drug discovery, drug development project management and global clinical operations. Steve’s passions are project, portfolio and governance management.